Manufacturer record
Orissa Drugs & Chemicals Ltd. 1: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Orissa Drugs & Chemicals Ltd. 1 (Odisha) was declared Not of Standard Quality in January 2020. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 9622, Albendazole Tablets I.P. 400mg (exp Jan 2022). RDTL Guwahati (state lab) found it not of standard quality: Dissolution. Listed in the January 2020 alert.
Records by type
1 record linked to Orissa Drugs & Chemicals Ltd. 1 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Albendazole Tablets I.P. 400mg | Batch 9622Mfg Feb 2019 · Exp Jan 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.